Complications from atherosclerosis cause most deaths in western countries, and their incidence appears to be markedly increasing in developing countries, thus suggesting a correlation that is directly proportional to social progress. In recent years, the different branches of medical research, from studies on vascular disease to those on lipid and glucose metabolism, and also clinical research on coronary, carotid and peripheral artery diseases, epidemiologic and pharmacologic research, have concentrated on these diseases with the common aim of reducing the incidence of cardiovascular diseases, and mortality. Scientific progress has greatly improved our understanding of the pathogenic mechanisms underlying the progression of cardiovascular disease, and efforts in this discipline now appear more necessary than ever.

Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future

BUEMI, Michele;ALOISI, Carmela;CAVALLARO, EMANUELA;CRASCI', eleonora;CRISEO, MANILA;CORICA, Francesco;FRISINA, Nicola
2005-01-01

Abstract

Complications from atherosclerosis cause most deaths in western countries, and their incidence appears to be markedly increasing in developing countries, thus suggesting a correlation that is directly proportional to social progress. In recent years, the different branches of medical research, from studies on vascular disease to those on lipid and glucose metabolism, and also clinical research on coronary, carotid and peripheral artery diseases, epidemiologic and pharmacologic research, have concentrated on these diseases with the common aim of reducing the incidence of cardiovascular diseases, and mortality. Scientific progress has greatly improved our understanding of the pathogenic mechanisms underlying the progression of cardiovascular disease, and efforts in this discipline now appear more necessary than ever.
2005
Inglese
STAMPA
11
3973
3984
12
Internazionale
Sì, ma tipo non specificato
Animals, Atherosclerosis; drug therapy/pathology, Bone Remodeling; drug effects, Cardiovascular Diseases; drug therapy/etiology/pathology, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors; therapeutic use, Immunologic Factors; therapeutic use, Inflammation; pathology, Muscle Tonus; drug effects, Muscle; Smooth; Vascular; drug effects, Renal Insufficiency; drug therapy/etiology/pathology.
info:eu-repo/semantics/article
Buemi, Michele; Aloisi, Carmela; Fulvio, F; Caccamo, C; Cavallaro, Emanuela; Crasci', Eleonora; Criseo, Manila; Corica, Francesco; Frisina, Nicola...espandi
14.a Contributo in Rivista::14.a.1 Articolo su rivista
9
262
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/1711613
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact